ENDO: Liraglutide May Benefit Adolescents With Obesity
Reduction in BMI standard-deviation score greater for liraglutide + lifestyle therapy versus placebo.
Diabetes Mellitus
Toujeo Max SoloStar Gets FDA Approval for Patients With Diabetes
Sanofi announced that the Food and Drug Administration (FDA) has approved Toujeo (insulin glargine 300 Units/mL) Max SoloStar, a long-acting insulin pen that holds 900 Units of Toujeo and provides up to 160 Units/mL per injection.
Dapagliflozin Evaluated in Patients With T2D and Moderate Renal Impairment
Farxiga is a sodium-glucose co-transporter 2 (SGLT2) inhibitor currently indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D mellitus.
Three New Type 2 Diabetes Treatments Get FDA Approval
Steglatro, Steglujan, and Segluromet have all received FDA approval for the treatment of type 2 diabetes.
Humalog Junior KwikPen Soon to Be Available
Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen.
Mediterranean Diet + Olive Oil – Diabetes
The Mediterranean diet received yet another endorsement for its disease-prevention qualities-this time for reducing the incidence of type 2 diabetes in a subgroup of a multicenter trial in Spain in which participants were randomly assigned to a Mediterranean diet supplemented with extra virgin …
